These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35332669)

  • 1. Comment on: Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know.
    Trüeb RM; Luu NC; Uribe NC; Régnier A
    J Cosmet Dermatol; 2022 Dec; 21(12):7200-7201. PubMed ID: 35332669
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
    Trüeb RM; Luu NC; Rezende HD
    J Am Acad Dermatol; 2022 Jul; 87(1):e29-e30. PubMed ID: 35304167
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients.
    Ismail FF; Meah N; Trindade de Carvalho L; Bhoyrul B; Wall D; Sinclair R
    J Am Acad Dermatol; 2020 Nov; 83(5):1478-1479. PubMed ID: 32213304
    [No Abstract]   [Full Text] [Related]  

  • 4. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know.
    Carvalho RM; Santos LDN; Ramos PM; Machado CJ; Acioly P; Frattini SC; Barcaui CB; Donda ALV; Melo DF
    J Cosmet Dermatol; 2022 Oct; 21(10):4171-4175. PubMed ID: 35032336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to: "Comment on: Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
    Moussa A; Kazmi A; Bokhari L; Sinclair RD
    J Am Acad Dermatol; 2022 Jul; 87(1):e31-e32. PubMed ID: 35304166
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral bicalutamide for female pattern hair loss: A pilot study.
    Fernandez-Nieto D; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones O; Jimenez-Cauhe J; Ortega-Quijano D; Vano-Galvan S
    Dermatol Ther; 2019 Nov; 32(6):e13096. PubMed ID: 31579984
    [No Abstract]   [Full Text] [Related]  

  • 7. Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss.
    Fernandez-Nieto D; Saceda-Corralo D; Jimenez-Cauhe J; Moreno-Arrones OM; Rodrigues-Barata R; Hermosa-Gelbard A; Vano-Galvan S
    J Am Acad Dermatol; 2020 Nov; 83(5):e355-e356. PubMed ID: 32320770
    [No Abstract]   [Full Text] [Related]  

  • 8. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients.
    Moussa A; Kazmi A; Bokhari L; Sinclair RD
    J Am Acad Dermatol; 2022 Aug; 87(2):488-490. PubMed ID: 34740752
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant hepatic failure associated with bicalutamide.
    Dawson LA; Chow E; Morton G
    Urology; 1997 Feb; 49(2):283-4. PubMed ID: 9037299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
    Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant hair regrowth in a Middle Eastern woman with central centrifugal cicatricial alopecia.
    Lobon K; Pinczewski J; Bhoyrul B
    Clin Exp Dermatol; 2022 Jan; 47(1):136-138. PubMed ID: 34192377
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
    Ferrari AC; Alumkal JJ; Stein MN; Taplin ME; Babb J; Barnett ES; Gomez-Pinillos A; Liu X; Moore D; DiPaola R; Beer TM
    Clin Cancer Res; 2019 Jan; 25(1):52-63. PubMed ID: 30224345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicalutamide-associated fulminant hepatotoxicity.
    O'Bryant CL; Flaig TW; Utz KJ
    Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia.
    Fu D; Huang J; Li K; Chen Y; He Y; Sun Y; Guo Y; Du L; Qu Q; Miao Y; Hu Z
    Biomed Pharmacother; 2021 May; 137():111247. PubMed ID: 33517191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicalutamide-associated fulminant hepatic failure.
    Chodak GW
    Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
    [No Abstract]   [Full Text] [Related]  

  • 16. Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development.
    Kolvenbag GJ; Blackledge GR; Gotting-Smith K
    Prostate; 1998 Jan; 34(1):61-72. PubMed ID: 9428389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicalutamide in advanced prostate cancer. A review.
    Goa KL; Spencer CM
    Drugs Aging; 1998 May; 12(5):401-22. PubMed ID: 9606617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure associated with bicalutamide.
    Schellhammer PF
    Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.
    Wong PW; Macris N; DiFabrizio L; Seriff NS
    Chest; 1998 Feb; 113(2):548-50. PubMed ID: 9498983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
    Zanardi S; Puntoni M; Maffezzini M; Bandelloni R; Mori M; Argusti A; Campodonico F; Turbino L; Branchi D; Montironi R; Decensi A
    Cancer Prev Res (Phila); 2009 Apr; 2(4):377-84. PubMed ID: 19336728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.